Strategic Partnerships Pacific BioLabs has engaged in strategic collaborations and memberships (e.g., West Coast Device Alliance) and is expanding capabilities (In Vitro Sciences) to broaden its service offerings for medical devices and pharma. This creates opportunities to cross-sell integrated testing programs and co-developed solutions with device manufacturers and biotech partners.

Regulatory Authority As a leading GMP/GLP lab with a strong quality and regulatory framework, PBL can position itself as a preferred partner for high-stakes projects requiring strict compliance, enabling upsell into complex toxicology, biocompatibility, and sterility testing for new product launches and regulatory submissions.

Talent & Expertise Recent hires and leadership additions in microbiology and quality assurance signal ongoing capability enhancements. This highlights opportunities to offer advanced training services, collaborative research, or targeted staffing solutions to expand client project throughput and reduce timelines.

Industry Focus Target customers span Medical Device, Pharmaceutical, and Biotechnology sectors on the West Coast, with an emphasis on timely, confidential, and high-integrity testing. Leverage this positioning to pursue new client wins with mid- to large-sized firms seeking reliable CRO partnerships and ongoing testing programs.

Service Expansion Launch of In Vitro Sciences and ongoing investments in biocompatibility, toxicology, and analytical chemistry capabilities open doors for multi-modality testing proposals, continuous run programs, and bundled service offerings that can improve client lifecycle value and reduce vendor fragmentation.